[1]
“A study to assess the safety and efficacy of full dose of Sofosbuvir and Daclatasvir in ESRD patients on Haemodialysis at GMC Anantnag”, VER, vol. 8, no. 5s, pp. 121–127, Nov. 2025, Accessed: Mar. 18, 2026. [Online]. Available: https://verjournal.com/index.php/ver/article/view/442